Work

Psychotropic Drug Treatment, Clinical Characteristics and Cognitive Processing Speed in Patients with Schizophrenia: Results from the ELAN Study

Year: 2011

Type: article

Source: Pharmacopsychiatry

DOI: 10.1055/s-0031-1297260

Authors: K. Frasch, P. Weiser, T. Becker, G. Längle, T. Steinert, C. Niederreiner, C. Pfiffner, S. Jäger, W. Bayer, G. Eschweiler, R. Kilian

Institutions: Universität Ulm, Zentrum für Psychiatrie Südwürttemberg, University of Tübingen, University Hospital Regensburg

Language: English

Topic: Schizophrenia research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Bristol-Myers Squibb, Eli Lilly and Company, AstraZeneca, Eberhard Karls Universität Tübingen

OpenAlex ID: W2055754061

FWCI: 1.091

Cites:

Cited by: 9

Related to: 10